3043 companies

Xintela

Market Cap: SEK 270.7m

A biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy.

XINT

SEK 0.39

7D

-11.8%

1Y

-17.7%

Cadrenal Therapeutics

Market Cap: US$28.7m

Operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions.

CVKD

US$14.03

7D

6.5%

1Y

-3.2%

FLUENT

Market Cap: US$28.7m

Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

FNT.U

US$0.045

7D

-10.0%

1Y

-74.3%

Prescient Therapeutics

Market Cap: AU$43.6m

A clinical stage oncology company, develops drugs for the treatment of various cancers in Australia.

PTX

AU$0.042

7D

-1.2%

1Y

6.4%

Human Metabolome Technologies

Market Cap: JP¥4.3b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

6090

JP¥750.00

7D

3.7%

1Y

21.6%

FunPep

Market Cap: JP¥4.3b

Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.

4881

JP¥105.00

7D

-3.7%

1Y

-27.1%

Rubicon Organics

Market Cap: CA$39.6m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

ROMJ

CA$0.59

7D

0%

1Y

34.1%

BDH Industries

Market Cap: ₹2.5b

Engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India and Internationally.

524828

₹435.80

7D

0.6%

1Y

31.2%

JSP Pharmaceutical Manufacturing (Thailand) Public

Market Cap: ฿911.2m

JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.

JSP

฿1.92

7D

6.1%

1Y

-9.4%

Carna Biosciences

Market Cap: JP¥4.2b

A clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan.

4572

JP¥221.00

7D

-0.9%

1Y

-43.6%

Regent Pacific Group

Market Cap: HK$218.9m

An investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific.

575

HK$0.75

7D

-5.1%

1Y

87.5%

Aptamer Group

Market Cap: UK£20.9m

Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

APTA

UK£0.0077

7D

-20.5%

1Y

229.8%

Klotho Neurosciences

Market Cap: US$27.9m

Develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders.

KLTO

US$0.45

7D

-17.6%

1Y

-38.1%

Syschem (India)

Market Cap: ₹2.5b

Engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India.

531173

₹56.72

7D

2.8%

1Y

33.4%

BioLASCO Taiwan

Market Cap: NT$847.8m

Provides bio-materials and surgical services in Taiwan and internationally.

6662

NT$33.10

7D

-1.2%

1Y

-9.3%

Fusion Antibodies

Market Cap: UK£20.7m

A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.

FAB

UK£0.18

7D

9.0%

1Y

319.5%

Vitura Health

Market Cap: AU$42.4m

Engages in the sale and distribution of medicinal cannabis products in Australia.

VIT

AU$0.064

7D

0%

1Y

-12.3%

Beit Jala Pharmaceutical

Market Cap: د.أ19.6m

Engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.

BJP

د.أ2.80

7D

0%

1Y

n/a

LAUNXP Biomedical

Market Cap: NT$842.2m

Engages in the research and development of drugs for cancer patients.

6876

NT$25.95

7D

0.8%

1Y

30.1%

DT&CRO

Market Cap: ₩38.9b

Operates as a full-service CRO provider in South Korea.

A383930

₩3,040.00

7D

-5.0%

1Y

-60.6%

Daré Bioscience

Market Cap: US$27.5m

Develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States.

DARE

US$2.09

7D

-1.4%

1Y

-36.1%

Rein Therapeutics

Market Cap: US$27.5m

A biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States.

RNTX

US$1.18

7D

-2.5%

1Y

-67.7%

Gemina Laboratories

Market Cap: CA$38.3m

A biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada.

GLAB

CA$0.50

7D

0%

1Y

11.1%

ProText Mobility

Market Cap: US$27.3m

A biotech company, engages in the development of pharmaceutical botanical medicines.

TXTM

US$0.0031

7D

3.3%

1Y

55.0%

European Medical Solutions

Market Cap: €23.3m

Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium.

ALEMS

€5.50

7D

-4.2%

1Y

-18.6%

Vidac Pharma Holding

Market Cap: €23.2m

An investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.

T9G

€0.45

7D

-8.2%

1Y

28.6%

Seach Medical Group

Market Cap: ₪90.9m

Manufactures and sells medicinal cannabis products worldwide.

SEMG

₪2.75

7D

0.1%

1Y

37.3%

BCWORLD PHARM

Market Cap: ₩38.1b

Operates as a pharmaceutical company in South Korea.

A200780

₩4,510.00

7D

3.2%

1Y

-1.4%

IRLAB Therapeutics

Market Cap: SEK 253.1m

IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.

IRLAB A

SEK 2.98

7D

-2.9%

1Y

-75.4%

Epibiotech

Market Cap: ₩37.8b

A biopharmaceutical research company, develops cell and antibody treatments for hair restoration medical needs.

A446440

₩16,390.00

7D

0.6%

1Y

56.1%

Sat Kartar Shopping

Market Cap: ₹2.4b

An ayurvedic healthcare company, provides ayurvedic products in India.

SATKARTAR

₹151.10

7D

-5.5%

1Y

n/a

Syntara

Market Cap: AU$40.8m

Operates as a clinical-stage drug development company that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia.

SNT

AU$0.025

7D

-3.8%

1Y

-35.9%

Kezar Life Sciences

Market Cap: US$26.7m

A clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States.

KZR

US$3.65

7D

-2.9%

1Y

-32.9%

GenSight Biologics

Market Cap: €22.8m

A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

SIGHT

€0.15

7D

-0.1%

1Y

-56.6%

Cryosite

Market Cap: AU$40.8m

Provides outsourced clinical trials logistic services in Australia.

CTE

AU$0.83

7D

-0.6%

1Y

4.4%

Baskhanbio Pharma

Market Cap: ₩37.5b

Provides pain medicines before and after surgery, and medical devices for surgical process in South Korea.

A354390

₩5,340.00

7D

-0.4%

1Y

21.4%

Page 56 of 85